Glycemic control, the unconsidered outcome in the treatment of nonalcoholic fatty liver disease

Ann Hepatol. 2022 Jan-Feb;27(1):100648. doi: 10.1016/j.aohep.2021.100648. Epub 2021 Dec 3.

¹ Department of Gastroenterology. University Hospital. Autonomous University of Nuevo León. Madero y Gonzalitos Colonia Mitras CP 64700 Monterrey, N.L. México. Electronic address: digarciacompean@prodigy.net.mx.
² Diabetes Service, Endocrinology and Metabolic Diseases Unit, IRCCS "Cà Granda - Ospedale Maggiore Policlinico" Foundation, and Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
³ Department of Gastroenterology, Toyonaka Municipal Hospital, 4-14-1 Shibahara, Toyonaka, Osaka 560-8565 Japan.
⁴ Department of Gastroenterology, OPD Block, All India Institute of Medical Sciences, Phulwari Sharif, Patna -801507, India.

No abstract available

Keywords: Diabetes Mellitus; Glycemic control; Liver fibrosis; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis.

Publication types